Zhejiang Ausun Pharmaceutical Co., Ltd. (603229.SS)
CNY 9.07
(3.66%)
CNY 9.07
(3.66%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.95 Billion CNY | 27.48% |
| 2022 | 2.31 Billion CNY | 25.87% |
| 2021 | 1.83 Billion CNY | 33.13% |
| 2020 | 1.38 Billion CNY | 55.92% |
| 2019 | 886.14 Million CNY | 10.49% |
| 2018 | 801.97 Million CNY | 8.14% |
| 2017 | 741.58 Million CNY | 66.25% |
| 2016 | 446.06 Million CNY | 10.99% |
| 2015 | 401.88 Million CNY | 54.51% |
| 2014 | 260.1 Million CNY | 45.49% |
| 2013 | 178.78 Million CNY | 45.86% |
| 2012 | 122.56 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.98 Billion CNY | -2.12% |
| 2024 Q3 | 3.01 Billion CNY | 1.24% |
| 2024 Q1 | 3.04 Billion CNY | 3.17% |
| 2023 Q2 | 3.01 Billion CNY | 3.82% |
| 2023 Q1 | 2.9 Billion CNY | 25.36% |
| 2023 Q3 | 2.97 Billion CNY | -1.33% |
| 2023 FY | 2.95 Billion CNY | 27.48% |
| 2023 Q4 | 2.95 Billion CNY | -0.73% |
| 2022 Q4 | 2.31 Billion CNY | 3.43% |
| 2022 Q3 | 2.23 Billion CNY | 5.24% |
| 2022 FY | 2.31 Billion CNY | 25.87% |
| 2022 Q1 | 1.94 Billion CNY | 5.54% |
| 2022 Q2 | 2.12 Billion CNY | 9.57% |
| 2021 FY | 1.83 Billion CNY | 33.13% |
| 2021 Q3 | 1.67 Billion CNY | 7.47% |
| 2021 Q1 | 1.38 Billion CNY | 0.05% |
| 2021 Q2 | 1.55 Billion CNY | 12.62% |
| 2021 Q4 | 1.83 Billion CNY | 9.94% |
| 2020 Q1 | 854.01 Million CNY | -3.63% |
| 2020 FY | 1.38 Billion CNY | 55.92% |
| 2020 Q2 | 894.11 Million CNY | 4.7% |
| 2020 Q3 | 912.94 Million CNY | 2.11% |
| 2020 Q4 | 1.38 Billion CNY | 51.34% |
| 2019 Q3 | 843.49 Million CNY | 10.43% |
| 2019 FY | 886.14 Million CNY | 10.49% |
| 2019 Q1 | 818.01 Million CNY | 2.0% |
| 2019 Q4 | 886.14 Million CNY | 5.06% |
| 2019 Q2 | 763.82 Million CNY | -6.62% |
| 2018 Q2 | 766.26 Million CNY | 3.12% |
| 2018 FY | 801.97 Million CNY | 8.14% |
| 2018 Q1 | 743.1 Million CNY | 0.2% |
| 2018 Q4 | 801.97 Million CNY | 2.05% |
| 2018 Q3 | 785.86 Million CNY | 2.56% |
| 2017 Q4 | 741.58 Million CNY | 8.06% |
| 2017 FY | 741.58 Million CNY | 66.25% |
| 2017 Q1 | 467.53 Million CNY | 4.81% |
| 2017 Q2 | 696.89 Million CNY | 49.06% |
| 2017 Q3 | 686.24 Million CNY | -1.53% |
| 2016 Q1 | - CNY | 0.0% |
| 2016 FY | 446.06 Million CNY | 10.99% |
| 2016 Q4 | 446.06 Million CNY | 0.0% |
| 2015 Q1 | 294.43 Million CNY | 0.0% |
| 2015 FY | 401.88 Million CNY | 54.51% |
| 2014 FY | 260.1 Million CNY | 45.49% |
| 2013 FY | 178.78 Million CNY | 45.86% |
| 2012 FY | 122.56 Million CNY | 0.0% |